Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01106898
Title Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Treating Women With Stage I or Stage II Breast Cancer Who Have Undergone Surgery
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska
Indications

breast cancer

Therapies

Cyclophosphamide + Paclitaxel

Trastuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.